Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 5010 entries
Sorted by: Best Match Show Resources per page
The PurR regulon in Escherichia coli K-12 MG1655

k-12

Cho BK, Embree M.
GSID: 77FsoKXzrk8J
BK Cho, SA Federowicz, M Embree… - Nucleic acids …, 2011 - academic.oup.com

The PurR transcription factor plays a critical role in transcriptional regulation of purine metabolism in enterobacteria. Here, we elucidate the role of PurR under exogenous adenine stimulation at the genome-scale using high-resolution chromatin immunoprecipitation (ChIP)–…

Cite
Cho, B. K., Federowicz, S. A., Embree, M., Park, Y. S., Kim, D., & Palsson, B. Ø. (2011). The PurR regulon in Escherichia coli K-12 MG1655. Nucleic acids research, 39(15), 6456-6464.
Cho, Byung-Kwan, et al. "The PurR regulon in Escherichia coli K-12 MG1655." Nucleic acids research 39.15 (2011): 6456-6464.
Copy Download .nbib Format: MLA
Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics …

discipline specific-education (e.g., chemistry education, biology education, economics education)

[No authors listed]
GSID: r81mkFsAmU8J
M Donnette, C Solas, M Giocanti, G Venton… - … of Chromatography B, 2019 - Elsevier

Purine analogs like aracytine (Arasingle bondC) are a mainstay for treating acute myeloid leukemia (AML). There are marked differences in drug dosing and scheduling depending on …

Cite
Donnette, M., Solas, C., Giocanti, M., Venton, G., Farnault, L., Berda-Haddad, Y., ... & Fanciullino, R. (2019). Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients. Journal of Chromatography B, 1126, 121770.
Donnette, Melanie, et al. "Simultaneous determination of cytosine arabinoside and its metabolite uracil arabinoside in human plasma by LC-MS/MS: Application to pharmacokinetics-pharmacogenetics pilot study in AML patients." Journal of Chromatography B 1126 (2019): 121770.
Copy Download .nbib Format: MLA
A modified intraoral resin mouthguard to prevent self-mutilations in lesch-nyhan patients.

International journal of dentistry

Ragazzini G, Delucchi A, Calcagno E, Servetto R, Denotti G.
PMID: 25101126
Int J Dent. 2014;2014:396830. doi: 10.1155/2014/396830. Epub 2014 Jul 02.

Lesch-Nyhan syndrome, described in 1964 by Lesch and Nyhan, is a X-linked recessive disorder, occurring in 1 : 100000 to 1 : 380000 live births. LNS is characterized by a decrease in activity of hypoxanthine guanine phosphoribosyl transferase, an...

Cite
Ragazzini G, Delucchi A, Calcagno E, et al. A modified intraoral resin mouthguard to prevent self-mutilations in lesch-nyhan patients. Int J Dent. 2014;2014:396830doi: 10.1155/2014/396830.
Ragazzini, G., Delucchi, A., Calcagno, E., Servetto, R., & Denotti, G. (2014). A modified intraoral resin mouthguard to prevent self-mutilations in lesch-nyhan patients. International journal of dentistry, 2014396830. https://doi.org/10.1155/2014/396830
Ragazzini, Giulia, et al. "A modified intraoral resin mouthguard to prevent self-mutilations in lesch-nyhan patients." International journal of dentistry vol. 2014 (2014): 396830. doi: https://doi.org/10.1155/2014/396830
Ragazzini G, Delucchi A, Calcagno E, Servetto R, Denotti G. A modified intraoral resin mouthguard to prevent self-mutilations in lesch-nyhan patients. Int J Dent. 2014;2014:396830. doi: 10.1155/2014/396830. Epub 2014 Jul 02. PMID: 25101126; PMCID: PMC4102014.
Copy Download .nbib Format: NLM
Biological and Medicinal Significance of Purines.

Mini reviews in medicinal chemistry

Chaskar P, Chaudhari S, Dighe S, More N.
PMID: 22931527
Mini Rev Med Chem. 2012 Aug 27; Epub 2012 Aug 27.

This article outlines the biological significance of one of the most important heterocycles, the purines. An attempt has been made to cover most of the physiologically as well as medicinally important compounds containing the purine derivatives. Purines are the...

Cite
Chaskar P, Chaudhari S, Dighe S, et al. Biological and Medicinal Significance of Purines. Mini Rev Med Chem. 2012;
Chaskar, P., Chaudhari, S., Dighe, S., & More, N. (2012). Biological and Medicinal Significance of Purines. Mini reviews in medicinal chemistry, .
Chaskar, Pratip, et al. "Biological and Medicinal Significance of Purines." Mini reviews in medicinal chemistry vol. (2012).
Chaskar P, Chaudhari S, Dighe S, More N. Biological and Medicinal Significance of Purines. Mini Rev Med Chem. 2012 Aug 27; Epub 2012 Aug 27. PMID: 22931527.
Copy Download .nbib Format: NLM
Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System.

Frontiers in molecular neuroscience

Jaafar C, Omais S, Al Lafi S, El Jamal N, Noubani M, Skaf L, Ghanem N.
PMID: 27667971
Front Mol Neurosci. 2016 Sep 09;9:81. doi: 10.3389/fnmol.2016.00081. eCollection 2016.

The Retinoblastoma protein, Rb, was shown to regulate distinct aspects of neurogenesis in the embryonic and adult brain besides its primary role in cell cycle control. It is still unknown, however, whether Rb is required for tissue morphogenesis and...

Cite
Jaafar C, Omais S, Al Lafi S, et al. Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System. Front Mol Neurosci. 2016;9:81doi: 10.3389/fnmol.2016.00081.
Jaafar, C., Omais, S., Al Lafi, S., El Jamal, N., Noubani, M., Skaf, L., & Ghanem, N. (2016). Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System. Frontiers in molecular neuroscience, 981. https://doi.org/10.3389/fnmol.2016.00081
Jaafar, Carine, et al. "Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System." Frontiers in molecular neuroscience vol. 9 (2016): 81. doi: https://doi.org/10.3389/fnmol.2016.00081
Jaafar C, Omais S, Al Lafi S, El Jamal N, Noubani M, Skaf L, Ghanem N. Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System. Front Mol Neurosci. 2016 Sep 09;9:81. doi: 10.3389/fnmol.2016.00081. eCollection 2016. PMID: 27667971; PMCID: PMC5016521.
Copy Download .nbib Format: NLM
Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects.

Frontiers in neuroscience

Chennaoui M, Arnal PJ, Drogou C, Leger D, Sauvet F, Gomez-Merino D.
PMID: 28512397
Front Neurosci. 2017 May 02;11:240. doi: 10.3389/fnins.2017.00240. eCollection 2017.

The purinergic type P1 (adenosine A

Cite
Chennaoui M, Arnal PJ, Drogou C, et al. Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects. Front Neurosci. 2017;11:240doi: 10.3389/fnins.2017.00240.
Chennaoui, M., Arnal, P. J., Drogou, C., Leger, D., Sauvet, F., & Gomez-Merino, D. (2017). Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects. Frontiers in neuroscience, 11240. https://doi.org/10.3389/fnins.2017.00240
Chennaoui, Mounir, et al. "Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects." Frontiers in neuroscience vol. 11 (2017): 240. doi: https://doi.org/10.3389/fnins.2017.00240
Chennaoui M, Arnal PJ, Drogou C, Leger D, Sauvet F, Gomez-Merino D. Leukocyte Expression of Type 1 and Type 2 Purinergic Receptors and Pro-Inflammatory Cytokines during Total Sleep Deprivation and/or Sleep Extension in Healthy Subjects. Front Neurosci. 2017 May 02;11:240. doi: 10.3389/fnins.2017.00240. eCollection 2017. PMID: 28512397; PMCID: PMC5411417.
Copy Download .nbib Format: NLM
Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia.

OncoTargets and therapy

Hill BT, Kalaycio M.
PMID: 26366093
Onco Targets Ther. 2015 Aug 31;8:2391-7. doi: 10.2147/OTT.S68770. eCollection 2015.

Chronic lymphocytic leukemia (CLL) is a hematologic malignancy derived from a clonal population of mature B-lymphocytes characterized by relatively low CD20 antigen expression. Although the disease often takes an indolent course, the majority of patients will eventually require therapy....

Cite
Hill BT, Kalaycio M. Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia. Onco Targets Ther. 2015;8:2391-7doi: 10.2147/OTT.S68770.
Hill, B. T., & Kalaycio, M. (2015). Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia. OncoTargets and therapy, 82391-7. https://doi.org/10.2147/OTT.S68770
Hill, Brian T, and Kalaycio, Matt. "Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia." OncoTargets and therapy vol. 8 (2015): 2391-7. doi: https://doi.org/10.2147/OTT.S68770
Hill BT, Kalaycio M. Profile of obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia. Onco Targets Ther. 2015 Aug 31;8:2391-7. doi: 10.2147/OTT.S68770. eCollection 2015. PMID: 26366093; PMCID: PMC4562745.
Copy Download .nbib Format: NLM
RASopathies: unraveling mechanisms with animal models.

Disease models & mechanisms

Jindal GA, Goyal Y, Burdine RD, Rauen KA, Shvartsman SY.
PMID: 26398161
Dis Model Mech. 2015 Sep;8(9):1167. doi: 10.1242/dmm.022442.

No abstract available.

Cite
Jindal GA, Goyal Y, Burdine RD, et al. RASopathies: unraveling mechanisms with animal models. Dis Model Mech. 2015;8(9):1167doi: 10.1242/dmm.022442.
Jindal, G. A., Goyal, Y., Burdine, R. D., Rauen, K. A., & Shvartsman, S. Y. (2015). RASopathies: unraveling mechanisms with animal models. Disease models & mechanisms, 8(9), 1167. https://doi.org/10.1242/dmm.022442
Jindal, Granton A, et al. "RASopathies: unraveling mechanisms with animal models." Disease models & mechanisms vol. 8,9 (2015): 1167. doi: https://doi.org/10.1242/dmm.022442
Jindal GA, Goyal Y, Burdine RD, Rauen KA, Shvartsman SY. RASopathies: unraveling mechanisms with animal models. Dis Model Mech. 2015 Sep;8(9):1167. doi: 10.1242/dmm.022442. PMID: 26398161; PMCID: PMC4582110.
Copy Download .nbib Format: NLM
Crystal structures of five 6-mercaptopurine derivatives.

Acta crystallographica. Section E, Crystallographic communications

Gomes LR, Low JN, Magalhães E Silva D, Cagide F, Borges F.
PMID: 27006794
Acta Crystallogr E Crystallogr Commun. 2016 Feb 10;72:307-13. doi: 10.1107/S2056989016001833. eCollection 2016 Mar 01.

The crystal structures of five 6-mercaptopurine derivatives, viz. 2-[(9-acetyl-9H-purin-6-yl)sulfan-yl]-1-(3-meth-oxy-phen-yl)ethan-1-one (1), C16H14N4O3S, 2-[(9-acetyl-9H-purin-6-yl)sulfan-yl]-1-(4-meth-oxy-phen-yl)ethan-1-one (2), C16H14N4O3S, 2-[(9-acetyl-9H-purin-6-yl)sulfan-yl]-1-(4-chloro-phen-yl)ethan-1-one (3), C15H11ClN4O2S, 2-[(9-acetyl-9H-purin-6-yl)sulfan-yl]-1-(4-bromo-phen-yl)ethan-1-one (4), C15H11BrN4O2S, and 1-(3-meth-oxy-phen-yl)-2-[(9H-purin-6-yl)sulfan-yl]ethan-1-one (5), C14H12N4O2S. Compounds (2), (3) and (4) are isomorphous and accordingly their mol-ecular and supra-molecular structures are...

Cite
Gomes LR, Low JN, Magalhães E Silva D, et al. Crystal structures of five 6-mercaptopurine derivatives. Acta Crystallogr E Crystallogr Commun. 2016;72:307-13doi: 10.1107/S2056989016001833.
Gomes, L. R., Low, J. N., Magalhães E Silva, D., Cagide, F., & Borges, F. (2016). Crystal structures of five 6-mercaptopurine derivatives. Acta crystallographica. Section E, Crystallographic communications, 72307-13. https://doi.org/10.1107/S2056989016001833
Gomes, Lígia R, et al. "Crystal structures of five 6-mercaptopurine derivatives." Acta crystallographica. Section E, Crystallographic communications vol. 72 (2016): 307-13. doi: https://doi.org/10.1107/S2056989016001833
Gomes LR, Low JN, Magalhães E Silva D, Cagide F, Borges F. Crystal structures of five 6-mercaptopurine derivatives. Acta Crystallogr E Crystallogr Commun. 2016 Feb 10;72:307-13. doi: 10.1107/S2056989016001833. eCollection 2016 Mar 01. PMID: 27006794; PMCID: PMC4778836.
Copy Download .nbib Format: NLM
Electronic Structures of Mono-Oxidized Copper and Nickel Phosphasalen Complexes.

Chemistry (Weinheim an der Bergstrasse, Germany)

Mustieles Marín I, Cheisson T, Singh-Chauhan R, Herrero C, Cordier M, Clavaguéra C, Nocton G, Auffrant A.
PMID: 28980736
Chemistry. 2017 Dec 19;23(71):17940-17953. doi: 10.1002/chem.201703390. Epub 2017 Nov 22.

Non-innocent ligands render the determination of the electronic structure in metal complexes difficult. As such, a combination of experimental techniques and quantum chemistry are required to correctly elucidate them. This paper deals with the one-electron oxidation of copper(II) and...

Cite
Mustieles Marín I, Cheisson T, Singh-Chauhan R, et al. Electronic Structures of Mono-Oxidized Copper and Nickel Phosphasalen Complexes. Chemistry. 2017;23(71):17940-17953doi: 10.1002/chem.201703390.
Mustieles Marín, I., Cheisson, T., Singh-Chauhan, R., Herrero, C., Cordier, M., Clavaguéra, C., Nocton, G., & Auffrant, A. (2017). Electronic Structures of Mono-Oxidized Copper and Nickel Phosphasalen Complexes. Chemistry (Weinheim an der Bergstrasse, Germany), 23(71), 17940-17953. https://doi.org/10.1002/chem.201703390
Mustieles Marín, Irene, et al. "Electronic Structures of Mono-Oxidized Copper and Nickel Phosphasalen Complexes." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 23,71 (2017): 17940-17953. doi: https://doi.org/10.1002/chem.201703390
Mustieles Marín I, Cheisson T, Singh-Chauhan R, Herrero C, Cordier M, Clavaguéra C, Nocton G, Auffrant A. Electronic Structures of Mono-Oxidized Copper and Nickel Phosphasalen Complexes. Chemistry. 2017 Dec 19;23(71):17940-17953. doi: 10.1002/chem.201703390. Epub 2017 Nov 22. PMID: 28980736.
Copy Download .nbib Format: NLM
Epigenetic control of HIV-1 post integration latency: implications for therapy.

Clinical epigenetics

Kumar A, Darcis G, Van Lint C, Herbein G.
PMID: 26405463
Clin Epigenetics. 2015 Sep 24;7:103. doi: 10.1186/s13148-015-0137-6. eCollection 2015.

With the development of effective combined anti-retroviral therapy (cART), there is significant reduction in deaths associated with human immunodeficiency virus type 1 (HIV-1) infection. However, the complete cure of HIV-1 infection is difficult to achieve without the elimination of...

Cite
Kumar A, Darcis G, Van Lint C, et al. Epigenetic control of HIV-1 post integration latency: implications for therapy. Clin Epigenetics. 2015;7:103doi: 10.1186/s13148-015-0137-6.
Kumar, A., Darcis, G., Van Lint, C., & Herbein, G. (2015). Epigenetic control of HIV-1 post integration latency: implications for therapy. Clinical epigenetics, 7103. https://doi.org/10.1186/s13148-015-0137-6
Kumar, Amit, et al. "Epigenetic control of HIV-1 post integration latency: implications for therapy." Clinical epigenetics vol. 7 (2015): 103. doi: https://doi.org/10.1186/s13148-015-0137-6
Kumar A, Darcis G, Van Lint C, Herbein G. Epigenetic control of HIV-1 post integration latency: implications for therapy. Clin Epigenetics. 2015 Sep 24;7:103. doi: 10.1186/s13148-015-0137-6. eCollection 2015. PMID: 26405463; PMCID: PMC4581042.
Copy Download .nbib Format: NLM
Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life.

Frontiers in microbiology

Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, Hugerth LW, Bindl L, Bottu J, Andersson AF, de Beaufort C, Wilmes P.
PMID: 28512451
Front Microbiol. 2017 May 02;8:738. doi: 10.3389/fmicb.2017.00738. eCollection 2017.

Perturbations to the colonization process of the human gastrointestinal tract have been suggested to result in adverse health effects later in life. Although much research has been performed on bacterial colonization and succession, much less is known about the...

Cite
Wampach L, Heintz-Buschart A, Hogan A, et al. Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Front Microbiol. 2017;8:738doi: 10.3389/fmicb.2017.00738.
Wampach, L., Heintz-Buschart, A., Hogan, A., Muller, E. E. L., Narayanasamy, S., Laczny, C. C., Hugerth, L. W., Bindl, L., Bottu, J., Andersson, A. F., de Beaufort, C., & Wilmes, P. (2017). Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Frontiers in microbiology, 8738. https://doi.org/10.3389/fmicb.2017.00738
Wampach, Linda, et al. "Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life." Frontiers in microbiology vol. 8 (2017): 738. doi: https://doi.org/10.3389/fmicb.2017.00738
Wampach L, Heintz-Buschart A, Hogan A, Muller EEL, Narayanasamy S, Laczny CC, Hugerth LW, Bindl L, Bottu J, Andersson AF, de Beaufort C, Wilmes P. Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Front Microbiol. 2017 May 02;8:738. doi: 10.3389/fmicb.2017.00738. eCollection 2017. PMID: 28512451; PMCID: PMC5411419.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 5010 entries